Clotrimazole 1% (Empecid L Cream, BAYB5097)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vaginal Candida
Conditions
Vaginal Candida
Trial Timeline
Jul 10, 2018 → Sep 3, 2021
NCT ID
NCT03599323About Clotrimazole 1% (Empecid L Cream, BAYB5097)
Clotrimazole 1% (Empecid L Cream, BAYB5097) is a pre-clinical stage product being developed by Bayer for Vaginal Candida. The current trial status is completed. This product is registered under clinical trial identifier NCT03599323. Target conditions include Vaginal Candida.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03599323 | Pre-clinical | Completed |
Competing Products
19 competing products in Vaginal Candida